Organon & Co.
OGN
NYSE
IPO2021
about OGN
Organon & Co. is a biopharmaceutical company that develops, manufactures, and sells a range of healthcare products, including contraceptives and other reproductive health solutions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $7.25 | $7.64 | $6.80 | $2.38B | 34.91M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$0.56 | 2.33 | 1.15 | 14.37% | 9.10% | 1.13% |